Strata Critical Medical (SRTA) Liabilities and Shareholders Equity (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $327.6 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 30.76% year-over-year to $327.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 16.4% YoY) and the FY2025 annual result came in at $325.5 million, up 26.8% from the prior year.
• Liabilities and Shareholders Equity improved to $327.6 million in Q1 2026 per SRTA's latest filing, from $325.5 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $335.1 million in Q3 2025 and bottomed at $250.6 million in Q1 2025.
• The 5-year median for Liabilities and Shareholders Equity is $320.2 million (2023), against an average of $303.3 million.
• The widest annual swing landed in 2024, when Liabilities and Shareholders Equity fell 12.97%; it then surged 30.76% in 2026.
• Tracing SRTA's Liabilities and Shareholders Equity over 5 years: stood at $325.0 million in 2022, then decreased by 9.26% to $294.9 million in 2023, then slipped by 12.97% to $256.7 million in 2024, then grew by 26.8% to $325.5 million in 2025, then grew by 0.66% to $327.6 million in 2026.
• Per Business Quant, the three latest SRTA Liabilities and Shareholders Equity figures stand at $327.6 million (Q1 2026), $325.5 million (Q4 2025), and $335.1 million (Q3 2025).

Peer Comparison